201. UCLA researchers uncover potential biomarkers of positive response to immunotherapy.
- Subjects
IMMUNOTHERAPY ,IMMUNE checkpoint inhibitors ,ANTIGEN presenting cells ,B cells ,BIOMARKERS - Abstract
"For example, combination of anti-PD1 treatments with CXCL13 or B cell-directed therapies may be strategies for patients who fail to respond to checkpoint immunotherapy alone." Keywords: Biomarkers; Cancer; Diagnostics and Screening; Diseases and Conditions; Drugs and Therapies; Genetics; Health and Medicine; Healthcare; Immunotherapy; Melanoma; Metastatic Melanoma; Oncology; Therapy; University of California - Los Angeles Health Sciences EN Biomarkers Cancer Diagnostics and Screening Diseases and Conditions Drugs and Therapies Genetics Health and Medicine Healthcare Immunotherapy Melanoma Metastatic Melanoma Oncology Therapy University of California - Los Angeles Health Sciences 26 26 1 07/10/23 20230710 NES 230710 2023 JUL 10 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- FINDINGS Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment. [Extracted from the article]
- Published
- 2023